• SHARE

Over two years since the emergence of COVID-19, Japan’s pharmaceutical companies are finally in the home stretch of introducing their vaccines in the country, a move that experts say will be extremely important from the perspective of self-reliance.

In an important step, Mitsubishi Tanabe Pharma Corp. group became the first Japanese company to receive approval for its COVID-19 vaccine, in Canada, late last month. It is considering applying for approval in Japan between July and September.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)